Status:
RECRUITING
Epileptogenic Network Visualisation With Advanced MRI
Lead Sponsor:
Cliniques universitaires Saint-Luc- Université Catholique de Louvain
Conditions:
Drug Resistant Epilepsy
Eligibility:
All Genders
3+ years
Phase:
NA
Brief Summary
The goal of this clinical trial is to improve non-invasive identification of epileptogenic networks in drug-resistant epileptic patient. The investigators aim to compare epileptogenic network identif...
Detailed Description
Patient identified for SEEG will undergo, prior to the implantation procedure an MRI with the following sequences: * 3D T1 * rsfMRI * multishell diffusion The rsfMRI will be post-processed to deline...
Eligibility Criteria
Inclusion
- Patient suffering from drug-resistant epilepsy
- Patient already selected for SEEG implantation as part of their epileptic networks
Exclusion
- Patient excluded from SEEG (pregnant women, children too young for the procedure, patient unable to undergo the procedure)
- Contra-indication for MRI
Key Trial Info
Start Date :
October 25 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 1 2029
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT06059157
Start Date
October 25 2023
End Date
October 1 2029
Last Update
March 18 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Cliniques Universitaires St-Luc
Brussels, Belgium, 1200